BridgeMD
Compares treatment options for Shoulder Dislocation
Official title Latarjet Versus Modified Eden-Hybinette for Anterior Shoulder Dislocation
ClinicalTrials.gov ID: NCT02913352
What this study is testing
- What it's testing
- Randomized clinical trial, parallel 1:1, comparing Latarjet to Modified Eden-Hybinette (iliac bone crest + capsular repair) for recurrent traumatic anterior glenohumeral dislocation.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 16 and older
You may be able to join if
- History of one or more previous episodes of traumatic glenohumeral dislocation;
- Anterior glenoid bone loss superior to 20% of its diameter, regardless of the ISIS score;
- Recurrence of glenohumeral dislocation in cases previously treated with arthroscopic Bankart repair, regardless of the ISIS score and severity of...
- Borderline bipolar bone lesions:
- Instability Severity Index Score of (ISIS) greater than or equal to 4 points, with anterior glenoid bone loss (bone Bankart lesion) greater than...
You likely can't join if
- Hill-Sachs lesion greater than 40% of the humeral head diameter (measured by the preoperative CT);
- Untreated seizures;
- Previously diagnosed rotator cuff complete tear;
- Fractures of the proximal humerus (except for Hill-Sachs lesions);
- Multidirectional instability;
- Advanced glenohumeral osteoarthritis (grade 3 Samilson and Pietro)
See the full eligibility criteria
- History of one or more previous episodes of traumatic glenohumeral dislocation;
- Anterior glenoid bone loss superior to 20% of its diameter, regardless of the ISIS score;
- Recurrence of glenohumeral dislocation in cases previously treated with arthroscopic Bankart repair, regardless of the ISIS score and severity of bone lesion of the glenoid;
- Borderline bipolar bone lesions:
- Instability Severity Index Score of (ISIS) greater than or equal to 4 points, with anterior glenoid bone loss (bone Bankart lesion) greater than 13.5% of their diameter, measured by the method described by Sugaya et al.;
- Hill-Sachs lesion and glenoid considered "off-track".
- Hill-Sachs lesion greater than 40% of the humeral head diameter (measured by the preoperative CT);
- Untreated seizures;
- Previously diagnosed rotator cuff complete tear;
- Fractures of the proximal humerus (except for Hill-Sachs lesions);
- Multidirectional instability;
- Advanced glenohumeral osteoarthritis (grade 3 Samilson and Pietro)
The study team makes the final eligibility decision.
Where it's taking place
- São Paulo, São Paulo, Brazil
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 16 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include São Paulo, São Paulo, Brazil. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.